BR0009541A - Emulsão, composição farmacêutica, e, método para preparar uma composição farmacêutica de emulsão óleo-em-água - Google Patents
Emulsão, composição farmacêutica, e, método para preparar uma composição farmacêutica de emulsão óleo-em-águaInfo
- Publication number
- BR0009541A BR0009541A BR0009541-9A BR0009541A BR0009541A BR 0009541 A BR0009541 A BR 0009541A BR 0009541 A BR0009541 A BR 0009541A BR 0009541 A BR0009541 A BR 0009541A
- Authority
- BR
- Brazil
- Prior art keywords
- emulsion
- pharmaceutical composition
- oil
- preparing
- propofol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"EMULSãO, COMPOSIçãO FARMACêUTICA, E, MéTODO PARA PREPARAR UMA COMPOSIçãO FARMACêUTICA DE EMULSãO óLEO-EM-áGUA". Proporciona-se formulações de emulsões anestésicas intravenosas de propofol que contêm concentrações suficientemente baixas de óleo de soja para produzir uma emulsão estável e, simultaneamente, proporcionar nutrientes reduzidos que inibem crescimento microbiano, desta forma proporcionando proteção contaminação microbiana acidental durante infusões IV prolongadas. Adicionalmente à inibição de crescimento microbiano devido a uma redução de nutrientes, a formulação apresenta inibição adicional inesperada devido a uma maior disponibilidade de propofol. A baixa concentração de óleo de soja também proporciona uma formulação que reduz as chances de sobrecarga de gordura quando administrada a pacientes cronicamente doentes durante um período prolongado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/286,159 US6100302A (en) | 1999-04-05 | 1999-04-05 | Propofol formulation with enhanced microbial characteristics |
| PCT/US2000/008378 WO2000059471A1 (en) | 1999-04-05 | 2000-03-29 | Propofol formulation with enhanced microbial characteristics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0009541A true BR0009541A (pt) | 2002-01-02 |
Family
ID=23097354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0009541-9A BR0009541A (pt) | 1999-04-05 | 2000-03-29 | Emulsão, composição farmacêutica, e, método para preparar uma composição farmacêutica de emulsão óleo-em-água |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6100302A (pt) |
| EP (1) | EP1165045A1 (pt) |
| JP (1) | JP2002541086A (pt) |
| KR (2) | KR100861820B1 (pt) |
| AU (1) | AU774259B2 (pt) |
| BR (1) | BR0009541A (pt) |
| CA (1) | CA2366793C (pt) |
| MX (1) | MXPA01010064A (pt) |
| WO (1) | WO2000059471A1 (pt) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| IL141095A0 (en) | 1998-08-19 | 2002-02-10 | Rtp Pharma Inc | Injectable aqueous dispersions of propofol |
| WO2001097779A2 (en) * | 2000-06-16 | 2001-12-27 | Rtp Pharma Inc. | Improved injectable dispersions of propofol |
| US6399087B1 (en) * | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| WO2003026632A2 (en) | 2001-09-26 | 2003-04-03 | Theravance, Inc. | Substituted phenol compounds useful for anesthesia and sedation |
| WO2003026611A2 (en) | 2001-09-26 | 2003-04-03 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| WO2003080027A1 (en) * | 2002-03-20 | 2003-10-02 | Elan Pharma International, Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| WO2003105817A1 (en) * | 2002-05-02 | 2003-12-24 | Fdl, Inc. | Novel parenteral composition comprising propofol |
| KR100459025B1 (ko) * | 2002-05-02 | 2004-12-03 | (주) 에프디엘 | 프로포폴을 함유하는 신규한 주사제용 조성물 |
| US7550155B2 (en) * | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| PL375874A1 (pl) * | 2002-07-29 | 2005-12-12 | Transform Pharmaceuticals, Inc. | Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu |
| AU2003286725B2 (en) * | 2002-10-29 | 2007-07-12 | Transform Pharmaceuticals, Inc. | Propofol with cysteine |
| LT1585548T (lt) | 2002-12-09 | 2018-09-25 | Abraxis Bioscience, Llc | Farmakologinių agentų kompozicijos ir įvedimo būdai |
| US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
| US8476010B2 (en) | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
| US8546453B2 (en) | 2003-08-14 | 2013-10-01 | Rensheng Zhang | Propofol compositions and methods for reducing pain associated with propofol injection |
| MX2007002941A (es) * | 2004-09-13 | 2007-05-24 | Bharat Serums & Vaccines Ltd | Composiciones de emulsion estables para administracion intravenosa que tienen eficacia libre de conservadores. |
| KR20080043793A (ko) * | 2005-08-05 | 2008-05-19 | 바라트 쎄럼스 앤드 백신스 리미티드 | 방부 효능을 갖는 정맥 프로포폴 에멀젼 조성물 |
| KR20080055804A (ko) * | 2005-08-12 | 2008-06-19 | 바라트 쎄럼스 앤드 백신스 리미티드 | 프로포폴을 포함하는 수성 마취 조성물 |
| BRPI0615292A8 (pt) * | 2005-08-31 | 2018-03-06 | Abraxis Bioscience Llc | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada |
| SI3311805T1 (sl) | 2005-08-31 | 2020-07-31 | Abraxis Bioscience, Llc | Sestave, ki zajemajo slabo vodotopne farmacevtske učinkovine in antimikrobna sredstva |
| US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| JP2013001700A (ja) * | 2011-06-21 | 2013-01-07 | Fujifilm Corp | プロポフォール含有水中油型エマルション組成物 |
| JP5759804B2 (ja) * | 2011-06-27 | 2015-08-05 | 富士フイルム株式会社 | 容器詰製剤 |
| MX374014B (es) | 2012-05-16 | 2020-07-24 | Mewa Singh | Composiciones farmaceuticas para la entrega de farmacos insolubles en agua. |
| CN104490780B (zh) * | 2015-01-16 | 2017-04-19 | 河北一品制药有限公司 | 一种丙泊酚脂肪乳注射液的制备方法 |
| US11622937B2 (en) | 2015-08-20 | 2023-04-11 | Mewa Singh | Polyphenolic polymer to make water-insoluble molecules become water-soluble |
| CN110478366A (zh) * | 2019-08-23 | 2019-11-22 | 宜昌人福药业有限责任公司 | 含非水溶性镇痛药的局部用组合物及其制备方法和用途 |
| US11992483B2 (en) | 2021-03-31 | 2024-05-28 | Cali Biosciences Us, Llc | Emulsions for local anesthetics |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1472793A (en) * | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
| AU691248B2 (en) * | 1994-02-04 | 1998-05-14 | Scotia Lipidteknik Ab | Oil-in-water emulsions |
| GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
| US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
| IL141095A0 (en) * | 1998-08-19 | 2002-02-10 | Rtp Pharma Inc | Injectable aqueous dispersions of propofol |
| US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
-
1999
- 1999-04-05 US US09/286,159 patent/US6100302A/en not_active Expired - Fee Related
-
2000
- 2000-03-29 EP EP00919842A patent/EP1165045A1/en not_active Withdrawn
- 2000-03-29 KR KR1020077010526A patent/KR100861820B1/ko not_active Expired - Fee Related
- 2000-03-29 BR BR0009541-9A patent/BR0009541A/pt not_active Application Discontinuation
- 2000-03-29 CA CA002366793A patent/CA2366793C/en not_active Expired - Fee Related
- 2000-03-29 JP JP2000609035A patent/JP2002541086A/ja active Pending
- 2000-03-29 AU AU40463/00A patent/AU774259B2/en not_active Ceased
- 2000-03-29 WO PCT/US2000/008378 patent/WO2000059471A1/en not_active Ceased
- 2000-03-29 KR KR1020017012652A patent/KR100741604B1/ko not_active Expired - Fee Related
- 2000-03-29 MX MXPA01010064A patent/MXPA01010064A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070058012A (ko) | 2007-06-07 |
| CA2366793A1 (en) | 2000-10-12 |
| WO2000059471A1 (en) | 2000-10-12 |
| KR20010112400A (ko) | 2001-12-20 |
| KR100861820B1 (ko) | 2008-10-07 |
| AU774259B2 (en) | 2004-06-24 |
| AU4046300A (en) | 2000-10-23 |
| CA2366793C (en) | 2009-06-02 |
| EP1165045A1 (en) | 2002-01-02 |
| US6100302A (en) | 2000-08-08 |
| MXPA01010064A (es) | 2002-06-21 |
| KR100741604B1 (ko) | 2007-07-20 |
| JP2002541086A (ja) | 2002-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0009541A (pt) | Emulsão, composição farmacêutica, e, método para preparar uma composição farmacêutica de emulsão óleo-em-água | |
| AU2001258588B2 (en) | O/W emulsion | |
| US6028108A (en) | Propofol composition comprising pentetate | |
| CA1272447A (en) | Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs | |
| RU2147432C1 (ru) | Эмульсии типа масло в воде, содержащие пропофол и эдетат | |
| AP1666A (en) | Quinolinone derivatives as tyrosine kinase inhibitors. | |
| DE60120659D1 (de) | Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon-induzierter nebenwirkungen | |
| DE60001223D1 (de) | Tris enthaltende propofol-formulierung | |
| AU2001258588A1 (en) | O/W emulsion | |
| JP2017081901A (ja) | 水中油型乳化組成物 | |
| BR0009535A (pt) | Misturas de cozimento contendo farinha e possuindo uma aprimorada vida de prateleira e método e meios para a sua preraração | |
| GEP20033046B (en) | Parenteral Cisplatin Emulsion | |
| JP2020033311A (ja) | 皮膚外用組成物 | |
| KR100903708B1 (ko) | 화장료 | |
| ES2179667T3 (es) | Nuevas formulaciones inyectables que contienen ramoplanina. | |
| JP7514598B2 (ja) | 皮膚外用組成物 | |
| IE890537L (en) | Pharmaceutical composition for the transdermal application of heparin | |
| JP2004300107A (ja) | 経皮消炎鎮痛剤組成物 | |
| JP2020033310A (ja) | 皮膚外用組成物 | |
| JP2020033309A (ja) | 皮膚外用組成物 | |
| KR960021036A (ko) | 콜치신을 유효성분으로 함유하는 항간독성 조성물 및 그 제조방법 | |
| SK287511B6 (sk) | Sterilná vodná kompozícia na parenterálne podanie | |
| MXPA01004004A (en) | Propofol composition comprising pentetate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O, 11,13 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |